reports
Texas Capital Names David Oman as Chief Risk Officer
Texas Capital Names David Oman as Chief Risk Officer DALLAS, May 21, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced the appointment of David Oman to serve as the firm’s Chief Risk Officer (CRO), effective June 10, 2024. Oman will report directly to Texas Capital’s President & Chief Executive Officer Rob C. Holmes and serve as a member of the firm’s Operating Committee. As previously announced, Tim Storms, Texas Capital’s current CRO will retire next month and continue to serve as an advisor to the firm through...
Sana Biotechnology Highlights Publication in Nature Biotechnology of N...
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sa...
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold f...
Larimar Therapeutics Announces FDA has Removed Partial Clinical Hold for Nomlabofusp Program in Friedreich’s Ataxia Food and Drug Administration (FDA) removed partial clinical hold following review of Phase 2 dose exploration study data Ongoing open label extension (OLE) study initially evaluating 25 mg; Larimar plans to dose escalate to 50 mg following further characterization of frataxin pharmacodynamics (PD) at the 25 mg doseInterim data from OLE study remains on track for Q4 2024Biologics License Application (BLA) submission targeted for 2H 2025 BALA CYNWYD, Pa., May 20, 2024 (GLOBE ...
NGL Energy Partners Announces Earnings Call
TULSA, Okla.--(BUSINESS WIRE)-- NGL Energy Partners LP (NYSE: NGL) announced today that it plans to issue its fiscal year ended March 31, 2024 earnings press release post-market close on Thursday, June 6, 2024. Members of NGL’s management team intend to host an earnings call following this release on Thursday, June 6, 2024 at 4:00 pm CDT to discuss its financial results. Analysts, investors, and other interested parties may join the webcast via the event link: or by dialing (888) 506-0062 and providing access code: 410412. An archived audio replay of the call will be available for 14 days, wh...
Texas Capital Bancshares, Inc. Appoints Mark Midkiff to Board of Direc...
Texas Capital Bancshares, Inc. Appoints Mark Midkiff to Board of Directors DALLAS, May 16, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced the appointment of Mark Midkiff to its Board of Directors, effective June 1, 2024. Midkiff will also serve as a member of the Board’s Risk Committee. Midkiff brings nearly three decades of experience to Texas Capital. Most recently, Midkiff served as chief risk officer at KeyCorp where he reported directly to the CEO. In this role, he oversaw comprehensive risk management fun...
- Jonathan Chaplin
The broadband Open Access model
We created a model to better understand the economics of Gigapower for both AT&T and Blackrock. Please use the model and give us your thoughts. The model clarifies the value of broadband assets generally. It also clarifies why we are likely to see similar JVs from Frontier, Lumen, and others. We will adapt this model for those instances in due course.
Texas Capital Appoints Steve Genyk to Lead New Public Finance Practice
Texas Capital Appoints Steve Genyk to Lead New Public Finance Practice DALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced that Steve Genyk has joined Texas Capital Securities (TCS), Texas Capital’s broker dealer subsidiary, as Managing Director, Head of Public Finance. In this new role, Genyk is responsible for building out TCS’s Public Finance business, which will provide municipal underwriting services to governments, nonprofits and institutions in the state of Texas and across the country. Ge...
- Jonathan Moreland
CNMD CONMED CORPORATION
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
ZOM ZOMEDICA PHARMACEUTICALS CORP
EYE NATIONAL VISION HOLDINGS
CDLX CARDLYTICS INC
ISDR ISSUER DIRECT CORP.
FSK FS KKR CAPITAL CORP
GO GROCERY OUTLET HOLDING
FNWB FIRST NORTHWEST BANCORP
FOUR SHIFT4 PAYMENTS
HQL INC.
TLS TEKLA LIFE SCIENCES INVESTORS
TMCI TELOS
FLYW TREACE MED CONCEPTS INC
BGS FLYWIRE CORP
DCGO B&G FOODS
BHVN INC.
GRNT DOCGO INC
VSTS_w BIOHAVEN LTD
BHRB GRANITE RIDGE RESOURCES INC
VESTIS CORPORATION
BURKE HERBERT FINANCIAL SERVICES CORP
- Jonathan Moreland
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
SAIA SAIA INC.
RYI RYERSON HOLDING CORPORATION
RM REGIONAL MANAGEMENT CORP
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
LTRX LANTRONIX INC.
KMPR KEMPER CORPORATION
HUBB HUBBELL INCORPORATED CLASS B
HOO HERBALIFE NUTRITION LTD.
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CNMD CONMED CORPORATION
AXS AXIS CAPITAL HOLDINGS LIMITED
AMH AMERICAN HOMES 4 RENT CLASS A
AIN ALBANY INTERNATIONAL CORP. CLASS A
HWBK HAWTHORN BANCSHARES
EFR ENERGY FUELS
SABR SABRE CORP.
ALPN ALPINE SELECT AG
HTLD HEARTLAND EXPRESS INC.
MAC MACERICH COMPANY
HI HILLENBRAND INC.
GLO CLOUGH GLOBAL OPPORTUNITIES FUND
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
CRVS CORVUS PHARMACEUTICALS
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
EAF GRAFTECH INTERNATIONAL
FRAF FRANKLIN FINANCIAL SERVICES CO.
BBDC BARINGS BDC INC.
GH GUARDANT HEALTH
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
CZR CAESARS ENTERTAINMENT INC
WSC WILLSCOT MOBILE MINI HOLDINGS CORP
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
TBBK INC.
MEGI THE BANCORP
NPCT INC.
RXO_w MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w RXO INC
NBBK BEYON 3D LTD
ASGI VESTIS CORPORATION
EYPT NB BANCORP INC.
DBD ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
EYEPOINT PHARMACEUTICALS
INC.
DIEBOLD NIXDORF INCORPORATED
- Jonathan Moreland
KMPR KEMPER CORPORATION
HOO HERBALIFE NUTRITION LTD.
CNMD CONMED CORPORATION
SABR SABRE CORP.
ALPN ALPINE SELECT AG
MAC MACERICH COMPANY
WDFC WD-40 COMPANY
PK PARK HOTELS & RESORTS INC.
EAF GRAFTECH INTERNATIONAL
BBDC BARINGS BDC INC.
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
PSTV PLUS THERAPEUTICS INC
CTOS CUSTOM TRUCK ONE SOURCE
NPCT INC.
BYON NUVEEN CORE PLUS IMPACT FD
VSTS_w BEYON 3D LTD
ASGI VESTIS CORPORATION
ABERDEEN STANDARD GLOBAL INFRASTRUCTURE INCOME FUND
The Tile Shop Reports First Quarter 2024 Results
The Tile Shop Reports First Quarter 2024 Results MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Tile Shop Holdings, Inc. (Nasdaq: TTSH) (the “Company”), a specialty retailer of natural stone, man-made and luxury vinyl tiles today announced results for its first quarter ended March 31, 2024. First Quarter 2024 Summary Net Sales Decreased 10.1%Comparable Store Sales Decreased 10.2% Gross Margin of 65.8%Net Income of $1.7 Million and Adjusted EBITDA of $7.4 MillionDiluted Earnings per Share of $0.04Cash Provided by Operating Activities of $18.6 MillionEnding Cash Balance of $24.0 Million an...
Larimar Therapeutics Reports First Quarter 2024 Operating and Financia...
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results First patient dosed in open label extension (OLE) study with 25 mg daily dosing of nomlabofusp; interim data on track for Q4 2024 Positive top-line Phase 2 dose exploration study data demonstrated nomlabofusp was generally well-tolerated with dose-dependent increases in tissue frataxin levels, reinforcing therapeutic potentialBiologics License Application (“BLA”) submission targeted for 2H 2025; discussions initiated with Food and Drug Administration (“FDA”) on potential to pursue accelerated approval pathwaySuc...
PennantPark Investment Corporation Announces 14.3% Increase of Its Mon...
PennantPark Investment Corporation Announces 14.3% Increase of Its Monthly Distribution to $0.08 per share and Financial Results for the Quarter Ended March 31, 2024 MIAMI, May 08, 2024 (GLOBE NEWSWIRE) -- PennantPark Investment Corporation (NYSE: PNNT) announced today its financial results for the second quarter ended March 31, 2024. HIGHLIGHTS Quarter ended March 31, 2024 (unaudited)($ in millions, except per share amounts) Assets and Liabilities: Investment portfolio(1)$1,238.2 Net assets$501.5 GAAP net asset value per share$7.69 Quarterly increase in...
Sana Biotechnology Reports First Quarter 2024 Financial Results and Bu...
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Ongoing ARDENT trial for SC291 continues in B-cell malignancies; expect to report additional data in 2024 Enrolling patients in the ongoing GLEAM trial for SC291 in B-cell mediated autoimmune diseases; expect to report initial clinical data in 2024 Enrolling patients in the ongoing VIVID trial for SC262 in relapsed/refractory B-cell malignancies; expect to rep...
EMCORE Reports Fiscal 2024 Second Quarter Results
EMCORE Reports Fiscal 2024 Second Quarter Results BUDD LAKE, NJ, May 08, 2024 (GLOBE NEWSWIRE) -- EMCORE Corporation (Nasdaq: EMKR), the world’s largest independent provider of inertial navigation solutions to the aerospace and defense industry, today announced results for the fiscal 2024 second quarter (2Q24) ended March 31, 2024. Management will host a conference call to discuss 2Q24 financial and business results on May 8, 2024 at 5:00 p.m. Eastern Time (ET). “Lower-than-expected revenue in the March quarter was primarily due to product shipment delays and declining revenue from our B...
- Jonathan Chaplin
Mercury Systems Reports Third Quarter Fiscal 2024 Results
Mercury Systems Reports Third Quarter Fiscal 2024 Results Q3 FY24 Bookings of $219.9 million; book-to-bill ratio of 1.06Q3 FY24 Revenue of $208.3 million; GAAP net loss and adjusted EBITDA ($44.6) million and ($2.4) million, respectivelyRecord backlog of $1.3 billion; up 17% year-over-year ANDOVER, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, ), reported operating results for the third quarter of fiscal year 2024, ended March 29, 2024. “In the third quarter of fiscal year 2024, we made solid progress in each of our four priority focus areas which incl...
Texas Capital Foundation Announces Second Annual Honors Awards Grant R...
Texas Capital Foundation Announces Second Annual Honors Awards Grant Recipients Grants totaling $250,000 will support four Texas nonprofit organizations DALLAS, May 07, 2024 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital, today announced the recipients of the Texas Capital Foundation’s second annual Honors Awards. The awards provide grants totaling $250,000 to support four nonprofit organizations addressing community needs across Texas. The Honors Awards are a signature program of the Texas Capital Foundation, which Texas Capital ...
Hillenbrand Inc: 4 directors
Four Directors at Hillenbrand Inc bought/maiden bought 6,237 shares at between 42.105USD and 42.690USD. The significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
Hawthorn Bancshares Inc: 1 director
A director at Hawthorn Bancshares Inc bought 15,000 shares at 19.626USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.